Amyloid light chain amyloidosis is a form of systemic amyloidosis that occurs due to mutation in the plasma cells of the bone marrow. It generally affects the heart and kidneys but may also affect the intestine, stomach, skin, and nerves. Shortness of breath, chest pain, fatigue, and poor appetite are the common symptoms of this condition. Steroids, immunotherapy, and chemotherapy are used to treat AL amyloidosis.
Bortezomib for AL Amyloidosis - A Complete Guide
The Bortezomib regimen consists of Bortezomib, Daratumumab, Hyaluronidase, Cyclophosphamide, and Dexamethasone. It is prescribed to treat AL amyloidosis.
Infections and Amyloidosis: An Intricate Connection
Infections play a dual role in both precipitating and complicating amyloidosis. Read below to know more.
AL Amyloidosis - Symptoms, Diagnosis, and Treatment
Light chain amyloidosis or AL amyloidosis is a rare type of the disorder, amyloidosis. Read the article below to learn about this disorder in detail.
Understanding AL Amyloidosis: A Complication of Multiple Myeloma
Multiple myeloma and AL amyloidosis are two distinct medical conditions that are related because they both involve abnormalities of plasma cells.
